SI-BONE To Present at The Canaccord Genuity 42nd Annual Growth Conference 2022
July 18, 2022 08:00 ET
|
SI-BONE, Inc.
SANTA CLARA, Calif., July 18, 2022 (GLOBE NEWSWIRE) -- SI-BONE, Inc. (Nasdaq: SIBN), a medical device company dedicated to solving musculoskeletal disorders of the sacropelvic anatomy, today...
SI-BONE, Inc. Announces FDA Clearance for Expanded Indication of the iFuse-TORQ® Implant System
June 13, 2022 08:00 ET
|
SI-BONE, Inc.
SANTA CLARA, Calif., June 13, 2022 (GLOBE NEWSWIRE) -- SI-BONE, Inc. (SIBN), (Nasdaq: SIBN), a Silicon Valley-based medical device company dedicated to solving musculoskeletal disorders of the...
SI-BONE, Inc. Receives FDA 510(k) Clearance for iFuse Bedrock Granite, a Breakthrough Pelvic Fixation and Fusion Technology
May 31, 2022 08:00 ET
|
SI-BONE, Inc.
SANTA CLARA, Calif., May 31, 2022 (GLOBE NEWSWIRE) -- SI-BONE, Inc., (Nasdaq: SIBN), a Silicon Valley-based medical device company dedicated to solving musculoskeletal disorders of the sacropelvic...
SI-BONE, Inc. Reports First Quarter 2022 Financial Results
May 09, 2022 16:02 ET
|
SI-BONE, Inc.
SANTA CLARA, Calif., May 09, 2022 (GLOBE NEWSWIRE) -- SI-BONE, Inc. (Nasdaq:SIBN), a medical device company dedicated to solving musculoskeletal disorders of the sacropelvic anatomy, today reported...
SI-BONE, Inc. Announces New Technology Add-On Payment for Breakthrough Adult Spinal Deformity Treatment
April 19, 2022 08:00 ET
|
SI-BONE, Inc.
SANTA CLARA, Calif., April 19, 2022 (GLOBE NEWSWIRE) -- SI-BONE, Inc., (Nasdaq: SIBN) a Silicon Valley-based medical device company dedicated to solving musculoskeletal disorders of the sacropelvic...
SI-BONE To Present at BofA Securities 2022 Healthcare Conference
April 18, 2022 16:03 ET
|
SI-BONE, Inc.
SANTA CLARA, Calif., April 18, 2022 (GLOBE NEWSWIRE) -- SI-BONE, Inc. (Nasdaq: SIBN), a medical device company dedicated to solving musculoskeletal disorders of the sacropelvic anatomy, today...
SI-BONE To Report First Quarter 2022 Financial Results on May 9, 2022
April 18, 2022 08:00 ET
|
SI-BONE, Inc.
SANTA CLARA, Calif., April 18, 2022 (GLOBE NEWSWIRE) -- SI-BONE, Inc. (Nasdaq: SIBN), a medical device company dedicated to solving musculoskeletal disorders of the sacropelvic anatomy, today...
SI-BONE, Inc. Reports Fourth Quarter and Full Year 2021 Financial Results and Issues 2022 Revenue Guidance
February 28, 2022 16:02 ET
|
SI-BONE, Inc.
SANTA CLARA, Calif., Feb. 28, 2022 (GLOBE NEWSWIRE) -- SI-BONE, Inc. (Nasdaq:SIBN), a medical device company dedicated to solving musculoskeletal disorders of the sacropelvic anatomy, today reported...
SI-BONE To Report Fourth Quarter and Full Year 2021 Financial Results on February 28, 2022
February 01, 2022 08:00 ET
|
SI-BONE, Inc.
SANTA CLARA, Calif., Feb. 01, 2022 (GLOBE NEWSWIRE) -- SI-BONE, Inc. (Nasdaq: SIBN), a medical device company dedicated to solving musculoskeletal disorders of the sacropelvic anatomy, today...
SI-BONE Announces Revenue for the Fourth Quarter and Full Year 2021
January 10, 2022 07:00 ET
|
SI-BONE, Inc.
SANTA CLARA, Calif., Jan. 10, 2022 (GLOBE NEWSWIRE) -- SI-BONE, Inc. (Nasdaq: SIBN) (“SI-BONE” or the “Company”), a medical device company dedicated to solving musculoskeletal disorders of the...